Your browser doesn't support javascript.
loading
Adenoviral delivery of a leukocyte-type 12 lipoxygenase ribozyme inhibits effects of glucose and platelet-derived growth factor in vascular endothelial and smooth muscle cells.
Patricia, M K; Natarajan, R; Dooley, A N; Hernandez, F; Gu, J L; Berliner, J A; Rossi, J J; Nadler, J L; Meidell, R S; Hedrick, C C.
Affiliation
  • Patricia MK; Division of Cardiology, Department of Experimental Pathology, University of California Los Angeles, USA.
Circ Res ; 88(7): 659-65, 2001 Apr 13.
Article in En | MEDLINE | ID: mdl-11304487
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Platelet-Derived Growth Factor / Endothelium, Vascular / RNA, Catalytic / Lipoxygenase Inhibitors / Glucose / Muscle, Smooth, Vascular Language: En Journal: Circ Res Year: 2001 Type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Platelet-Derived Growth Factor / Endothelium, Vascular / RNA, Catalytic / Lipoxygenase Inhibitors / Glucose / Muscle, Smooth, Vascular Language: En Journal: Circ Res Year: 2001 Type: Article Affiliation country: United States